These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 30873742)

  • 1. Glutathione S-transferase omega 1 inhibition activates JNK-mediated apoptotic response in breast cancer stem cells.
    Manupati K; Debnath S; Goswami K; Bhoj PS; Chandak HS; Bahekar SP; Das A
    FEBS J; 2019 Jun; 286(11):2167-2192. PubMed ID: 30873742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibiting epidermal growth factor receptor signalling potentiates mesenchymal-epithelial transition of breast cancer stem cells and their responsiveness to anticancer drugs.
    Manupati K; Dhoke NR; Debnath T; Yeeravalli R; Guguloth K; Saeidpour S; De UC; Debnath S; Das A
    FEBS J; 2017 Jun; 284(12):1830-1854. PubMed ID: 28398698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutathione transferase omega 1-1 (GSTO1-1) plays an anti-apoptotic role in cell resistance to cisplatin toxicity.
    Piaggi S; Raggi C; Corti A; Pitzalis E; Mascherpa MC; Saviozzi M; Pompella A; Casini AF
    Carcinogenesis; 2010 May; 31(5):804-11. PubMed ID: 20106899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutathione-S-transferase omega 1 (GSTO1-1) acts as mediator of signaling pathways involved in aflatoxin B1-induced apoptosis-autophagy crosstalk in macrophages.
    Paul S; Jakhar R; Bhardwaj M; Kang SC
    Free Radic Biol Med; 2015 Dec; 89():1218-30. PubMed ID: 26561775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Koenimbin, a natural dietary compound of Murraya koenigii (L) Spreng: inhibition of MCF7 breast cancer cells and targeting of derived MCF7 breast cancer stem cells (CD44(+)/CD24(-/low)): an in vitro study.
    Ahmadipour F; Noordin MI; Mohan S; Arya A; Paydar M; Looi CY; Keong YS; Siyamak EN; Fani S; Firoozi M; Yong CL; Sukari MA; Kamalidehghan B
    Drug Des Devel Ther; 2015; 9():1193-208. PubMed ID: 25759564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutathione S‑transferase ω 1 promotes the proliferation, migration and invasion, and inhibits the apoptosis of non‑small cell lung cancer cells, via the JAK/STAT3 signaling pathway.
    Wang K; Zhang FL; Jia W
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic evaluation and transcriptional signature of a glutathione S-transferase omega 1 inhibitor.
    Ramkumar K; Samanta S; Kyani A; Yang S; Tamura S; Ziemke E; Stuckey JA; Li S; Chinnaswamy K; Otake H; Debnath B; Yarovenko V; Sebolt-Leopold JS; Ljungman M; Neamati N
    Nat Commun; 2016 Oct; 7():13084. PubMed ID: 27703239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elimination of the differential chemoresistance between the murine B-cell lymphoma LY-ar and LY-as cell lines after arsenic (As2O3) exposure via the overexpression of gsto1 (p28).
    Giri U; Terry NH; Kala SV; Lieberman MW; Story MD
    Cancer Chemother Pharmacol; 2005 Jun; 55(6):511-21. PubMed ID: 15761769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent and selective inhibitors of glutathione S-transferase omega 1 that impair cancer drug resistance.
    Tsuboi K; Bachovchin DA; Speers AE; Spicer TP; Fernandez-Vega V; Hodder P; Rosen H; Cravatt BF
    J Am Chem Soc; 2011 Oct; 133(41):16605-16. PubMed ID: 21899313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Triple Combination of Metformin, Acetylsalicylic Acid, and Oseltamivir Phosphate Impacts Tumour Spheroid Viability and Upends Chemoresistance in Triple-Negative Breast Cancer.
    Sambi M; Samuel V; Qorri B; Haq S; Burov SV; Markvicheva E; Harless W; Szewczuk MR
    Drug Des Devel Ther; 2020; 14():1995-2019. PubMed ID: 32546966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-in-class candidate therapeutics that target mitochondria and effectively prevent cancer cell metastasis: mitoriboscins and TPP compounds.
    Ózsvári B; Sotgia F; Lisanti MP
    Aging (Albany NY); 2020 May; 12(11):10162-10179. PubMed ID: 32452826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-Jun N-terminal kinase promotes stem cell phenotype in triple-negative breast cancer through upregulation of Notch1 via activation of c-Jun.
    Xie X; Kaoud TS; Edupuganti R; Zhang T; Kogawa T; Zhao Y; Chauhan GB; Giannoukos DN; Qi Y; Tripathy D; Wang J; Gray NS; Dalby KN; Bartholomeusz C; Ueno NT
    Oncogene; 2017 May; 36(18):2599-2608. PubMed ID: 27941886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oestrogen receptor-regulated glutathione S-transferase mu 3 expression attenuates hydrogen peroxide-induced cytotoxicity, which confers tamoxifen resistance on breast cancer cells.
    Lin JH; Tu SH; Chen LC; Huang CC; Chang HL; Cheng TC; Chang HW; Wu CH; Wu HC; Ho YS
    Breast Cancer Res Treat; 2018 Nov; 172(1):45-59. PubMed ID: 30054830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycophenotype of breast and prostate cancer stem cells treated with thieno[2,3-
    Mastelić A; Čikeš Čulić V; Režić Mužinić N; Vuica-Ross M; Barker D; Leung EY; Reynisson J; Markotić A
    Drug Des Devel Ther; 2017; 11():759-769. PubMed ID: 28352152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pranlukast Antagonizes CD49f and Reduces Stemness in Triple-Negative Breast Cancer Cells.
    Velázquez-Quesada I; Ruiz-Moreno AJ; Casique-Aguirre D; Aguirre-Alvarado C; Cortés-Mendoza F; de la Fuente-Granada M; García-Pérez C; Pérez-Tapia SM; González-Arenas A; Segura-Cabrera A; Velasco-Velázquez MA
    Drug Des Devel Ther; 2020; 14():1799-1811. PubMed ID: 32494122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of caspase-3 and c-Jun NH2-terminal kinase-1 signaling pathways in tamoxifen-induced apoptosis of human breast cancer cells.
    Mandlekar S; Yu R; Tan TH; Kong AN
    Cancer Res; 2000 Nov; 60(21):5995-6000. PubMed ID: 11085519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of CD44-Lipoprotein lipase axis in breast cancer stem cells promotes tumorigenesis.
    Manupati K; Yeeravalli R; Kaushik K; Singh D; Mehra B; Gangane N; Gupta A; Goswami K; Das A
    Biochim Biophys Acta Mol Basis Dis; 2021 Nov; 1867(11):166228. PubMed ID: 34311079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A2B adenosine receptor agonist induces cell cycle arrest and apoptosis in breast cancer stem cells via ERK1/2 phosphorylation.
    Jafari SM; Joshaghani HR; Panjehpour M; Aghaei M
    Cell Oncol (Dordr); 2018 Feb; 41(1):61-72. PubMed ID: 29218545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ZEB1 potentiates chemoresistance in breast cancer stem cells by evading apoptosis.
    Shivhare S; Choudhury S; Singh D; Das A
    Biochim Biophys Acta Mol Cell Res; 2023 Oct; 1870(7):119528. PubMed ID: 37356459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stat3/Oct-4/c-Myc signal circuit for regulating stemness-mediated doxorubicin resistance of triple-negative breast cancer cells and inhibitory effects of WP1066.
    Cheng CC; Shi LH; Wang XJ; Wang SX; Wan XQ; Liu SR; Wang YF; Lu Z; Wang LH; Ding Y
    Int J Oncol; 2018 Jul; 53(1):339-348. PubMed ID: 29750424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.